Kyverna Therapeutics, Inc.

NASDAQ:KYTX

Biotechnology

Healthcare
$4.48 -1.44%

-$0.12 today

Market cap
$283.23M
Beta
1.96
P/E (TTM)
-3.1
EPS (TTM)
-$2.59
52W Low $2.52High $13.67

Volume 1.05M

Average 0.94M

Balance Sheet

Inspect the capital base behind the business.

Assets

$293.83M

FY 2025 · Annual

-3.6% YoY

Liabilities

$61.55M

FY 2025 · Annual

+61.7% YoY

Equity

$232.28M

FY 2025 · Annual

-12.9% YoY

Balance Sheet

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Cash & Equivalents76.07M37.74M34.65M96.62M124.09M
Short-term Investments013.59M22.9M189.36M155.16M
Net Receivables00000
Inventory00000
Other Current Assets1.02M1.93M3.12M4.62M3.7M
Total Current Assets77.09M53.25M60.66M290.6M282.95M
Property, Plant & Equipment (Net)7.81M12.44M10.61M10.66M5.42M
Goodwill00000
Intangible Assets00000
Long-term Investments00000
Tax Assets00000
Other Non-current Assets593K1.23M3.92M5.26M5.45M
Total Non-current Assets8.4M13.67M14.53M15.92M10.87M
Total Assets85.49M66.92M75.2M304.65M293.83M
Account Payables773K1.45M4.36M4.62M5.31M
Short-term Debt00000
Tax Payables00000
Deferred Revenue6M0000
Other Current Liabilities1.72M565K9.77M4.88M9.99M
Total Current Liabilities15.93M11.95M19.86M33.76M36.49M
Long-term Debt000024.74M
Deferred Tax Liabilities00000
Deferred Revenue (Non-current)1.03M0000
Other Non-current Liabilities110.05M6K000
Total Non-current Liabilities115.81M8.29M6.16M4.3M25.06M
Total Liabilities131.74M20.25M26.02M38.06M61.55M
Common Stock00001K
Retained Earnings(46.78M)(75.68M)(136.04M)(263.52M)(424.83M)
Accumulated OCI0(26K)4K105K97K
Other Stockholders Equity0(0)000
Minority Interest00000
Total Equity(46.25M)46.68M49.18M266.59M232.28M
Total Debt5.56M10.56M9.08M8.24M29.03M
Net Debt(70.51M)(27.17M)(25.57M)(88.38M)(95.06M)

Balance Sheet

Assets, liabilities & equity

Cash & Equivalents$32.2M
Short-term Investments$204.3M
Other Current$5.3M
Total Current Assets$241.7M
PP&E (Net)$9.7M
Other Non-current$5.6M
Total Non-current Assets$15.3M
Total Assets$257.0M

Analysis

Selected assets total $257.0M for Latest. The largest visible component is Short-term Investments at $204.3M, about 79.5% of the tab total. Use the mix to judge balance sheet concentration, liquidity, leverage, and how much of book value is supported by tangible operating assets.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
8-KCurrent reportNov 12, 2026
10-QQuarterly reportNov 12, 2026
SC 13GSC 13G filingOct 19, 2026
8-KCurrent reportSep 24, 2026
SC 13G/ASC 13G/A filingAug 14, 2026

How much cash does KYTX have?

Kyverna Therapeutics, Inc. (KYTX) reported $124.09M in cash and equivalents in fiscal 2025.

How much debt does KYTX carry?

Kyverna Therapeutics, Inc. (KYTX) reported $29.03M of total debt, with net debt of -$95.06M.